Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea

Eur Respir J. 2021 Mar 4;57(3):2003026. doi: 10.1183/13993003.03026-2020. Print 2021 Mar.

¹ Dept of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, South Korea.
² Dept of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea.
³ Dept of Chest Medicine, Masan National Tuberculosis Hospital, Masan, South Korea.
⁴ Division of Pulmonary and Critical Care Medicine, Dept of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
⁵ Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea [email protected].

No abstract available

Publication types